| Name | I-138 |
|---|---|
| Synonyms |
7,9-Dihydro-2-[2-(1-methylethyl)phenyl]-9-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-8H-purin-8-one
2-(2-Isopropylphenyl)-9-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)benzyl)-7,9-dihydro-8H-purin-8-one I-138, 10 mM in DMSO |
| Description | I-138 is an orally active compound structurally related to ML323 (HY-17543). I-138 and ML-323 are potent reversible inhibitors of USP1-UAF1. I-138 displays synergistic binding with ubiquitin and mutual exclusive binding with ML323. I-138 induces the monoubiquitination of FANCD2 and PCNA in MDA-MB-436 cells, increases PCNA and FANCD2 monoubiquitination in HAP-1 USP1 WT cells. I-138 ablates USP1 autocleavage in cells[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C26H23F3N6O |
|---|---|
| Molecular Weight | 492.50 |